This inventor holds 1 USPTO granted patent. Top assignee: Sungkyunkwan University. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Selim Ahmed: Innovator in Cancer Treatment
Introduction
Selim Ahmed is a prominent inventor based in Suwon, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compositions.
Latest Patents
Selim Ahmed holds a patent for a pharmaceutical composition aimed at preventing or treating cancers. This composition includes dendritic cells with a silenced Dab2 gene. The invention is designed to enhance antigen uptake, improve the migration ability of cells to lymph nodes, and increase the expression of inflammatory cytokines. This innovative approach is expected to activate antigen-specific cytotoxic T cell lymphocytes (CTL) and related T cells, which can effectively target and attack cancer cells.
Career Highlights
Selim Ahmed is affiliated with Sungkyunkwan University, where he conducts his research. His work focuses on developing advanced therapeutic strategies for cancer treatment, showcasing his commitment to improving patient outcomes.
Collaborations
Selim collaborates with notable colleagues, including Yong-Soo Bae and Se Eun Byeon, to further enhance the impact of his research in the field of oncology.
Conclusion
Selim Ahmed's innovative work in cancer treatment exemplifies the potential of scientific research to transform healthcare. His contributions are paving the way for new therapeutic options that could significantly improve the lives of cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile